Acute respiratory distress syndrome (ARDS) complicates nosocomial pneumonias (NPn) in 12% to 33% of patients with associated increases in mortality of up to 80%. A timely diagnosis of ARDS with NPn is, however, problematic. The aim of this investigation was to improve the diagnosis and treatment of the early stages of ARDS with NPn.
Introduction
According to the classification of acute respiratory distress syndrome (ARDS) 1 that was developed at the V. A. Negovsky Research Institute of General Reanimatology, there are 3 phases of ARDS: reversible acute lung injury, progressive respiratory insufficiency, and a terminal phase. Nosocomial pneumonia (NPn) constitutes up to 20% of all pneumonias in intensive care units (ICUs) and is associated with greater than 70% mortality. 2 NPn are complicated by ARDS in 12% to 33% of patients, which is associated with mortality increases of up to 80%. 3, 4 The timely diagnosis of ARDS in NPn is a problem of scientific and practical significance because the treatment of ARDS differs markedly from that of NPn. 5, 6 Protective ventilation and corticosteroids during the early stages of ARDS decrease mortality. 7 Precise diagnostic tools for ARDS in the presence of NPn are required to start these treatment modalities. The aim of the investigation was to improve the accuracy of diagnosis and treatment of the early stages of ARDS in NPn.
Materials and Methods
The present study was performed in the ICU of the N. N. Burdenko Main Military Clinical Hospital, Moscow, Russia, from 2004 to 2010. Patients from the ages of 18 to 30 years presenting either with severe trauma or cancer that required invasive measurements of filling pressures and cardiac output postoperatively were eligible for inclusion. The exclusion criteria included (a) left ventricular insufficiency based on clinical data including indices of preload; (b) relative contraindications to femoral artery catheterization (severe atherosclerotic damage, international normalized ratio [INR] >2, platelets <50 × 10 9 /L, infection at the cannulation site); (c) community-acquired pneumonia or aspiration pneumonia; (d) chest trauma; (e) APACHE II score >26; (f) immune deficiency; (g) severe concomitant diabetes mellitus or renal, hepatic, cardiac, or atherosclerotic disease; and (h) hypoproteinemia (total protein <65 g/L, albumin <20 g/L). A total of 82 patients (out of 350 totally analyzed) were enrolled in the study according to the inclusion and exclusion criteria. Of the total cohort, 70.7% (n = 58) of patients were enrolled prospectively and 29.3% (n = 24) were enrolled retrospectively. The investigation was approved by the Institutional Human Investigations Committee.
Patients were divided into 3 groups on the day of enrollment: group 1 ("ARDS + NPn"), positive diagnostic criteria for ARDS and NPn; group 2 ("NPn"), positive diagnostic criteria only for NPn; and group 3 ("comparison group"), no signs of ARDS, no signs of NPn. Each group was subdivided into either "Trauma" or "Cancer." The diagnosis of NPn was made using the national Russian guidelines 8 as well as the Clinical Pulmonary Infection Score (CPIS). 9 ARDS was diagnosed in 2 steps using 3 different methods. First, the Murray lung injury score (published 1988) 10 and the American-European Consensus Conference on ARDS (published 1992) criteria 11 were used. Second, after obtaining data regarding transpulmonary thermodilution within 1 to 2 hours, the aforementioned criteria were compared with the ARDS criteria of the V. A. Negovsky Research Institute of General Reanimatology (published 2006; see the appendix), 1, 12, 13 and the patients were reclassified. In patients diagnosed with ARDS, the stage of ARDS was determined according to the classification of the V. A. Negovsky Research Institute of General Reanimatology (published 2007). 1 The diagnosis of sepsis was made according to standard criteria. 14 All patients underwent the following investigation protocol: APACHE II scoring on day 1; daily physical examinations, assessment of blood gases, central hemodynamics, extravascular lung water index (EVLWI) and pulmonary vascular permeability index (PVPI), fluid balance, ventilatory parameters, and total blood count. Once every 3 days, the Murray and CPIS scores were assessed, and we performed chest radiography, blood cultures, and bronchoalveolar lavage fluid (BAL) cultures. Arterial and mixed venous blood gases were analyzed using the Bayer 865 Blood Gas Analyzer (Bayer, Leverkusen, Germany). Total blood count was performed by an automated hematological analyzer Advia 60 (Bayer, Leverkusen, Germany). All patients were mechanically ventilated at the time of enrollment. Respiratory support was performed using Puritan Bennett 7200, 760, 800 (Puritan Bennett Corporation, Boulder, CO). Synchronized intermittent mandatory ventilation (SIMV) and bilevel positive airway pressure (BIPAP; volume or pressure controlled) ventilation modes were used. ARDS patients were ventilated in accordance with a protective ventilation strategy.
Transpulmonary thermodilution was performed using the Pulsion PiCCO Plus (Pulsion Medical Systems, Munich, Germany). The femoral artery was catheterized for invasive monitoring (Pulsiocath PV2015L20 + PCCO Monitoring kit 5 mV/V/mm Hg PV8115). The femoral arterial catheter was indwelling for no more than 10 days. It was periodically flushed with heparinized saline solution (1 U/mL). Patient height and weight were measured before the first calibration by electronic scales (Seca, Vogel & Halke, Hamburg, Germany). A solution of 15 mL of 0°С saline solution was used as a cold indicator. Three subsequent cold dilutions were performed for monitor calibration. There were 2 to 3 calibrations daily or more in case of patient instability.
The following parameters were recorded: heart rate (HR), systolic blood pressure (BPsys), diastolic blood pressure (BPdia), mean blood pressure (BPmean), central venous pressure (CVP), stroke volume (SV), cardiac output (CO), systemic vascular resistance (SVR), global end-diastolic volume (GEDV), intrathoracic blood volume (ITBV), and extravascular lung water (EVLW); their corresponding indexed values and pulmonary vascular permeability index (PVPI) were analyzed.
Anterioposterior chest radiographs were performed in the intensive care unit with Siemens Polymobil 10 (Siemens, Munich, Germany). Microbiologic studies were performed in accordance with generally accepted rules of specimen collection, storage, transportation, and processing. BAL was collected during fiberoptic bronchoscopy. BAL and blood were cultured to detect aerobes, anaerobes, and fungi. Statistica 7.0 (Statsoft, Inc., Tulsa, OK) was used for the statistical calculations. Means ± standard deviations are presented. Newman-Keuls tests and linear regression analyses were performed. A 2-tailed P value less than .05 was considered statistically significant.
Results
The characteristics of groups and subgroups are presented in Table 1 . Group 1 included 19 cancer patients (56%) and 15 with severe trauma (44%); group 2 included 24 cancer patients (46%) and 13 with severe trauma (54%); and group 3 included 11 cancer patients (46%) and 13 with severe trauma (54%).
Cancer diagnoses included esophageal cancer (n = 8, 42% in group 1; n = 4, 36% in group 2; n = 2, 18% in group 3), stomach cancer (n = 5, 26% in group 1; n = 5, 45% in group 2; n = 8, 73% in group 3), colon cancer (n = 6, 32% in group 1; n = 1, 9% in group 3), and hepatobiliary cancer (n = 2, 18% in group 2). The categories of multiple trauma included closed abdominal trauma and extremity trauma (n = 6, 40% in group 1; n = 7, 54% in group 2; n = 6, 46% in group 3); closed head trauma and closed abdominal trauma (n = 9, 60% in group 1; n = 6, 46% in group 2; n = 5, 38% in group 3), and closed head trauma and extremity trauma (n = 2, 15% in group 3). Patients with head trauma were assessed by Glasgow Coma Scale (score range: 4 to 7). All head trauma patients had epidural and/or subdural hematomas, which were surgically evacuated.
NPn was diagnosed in 30 patients of the cancer subgroup and in 26 patients of the multiple trauma subgroup. Microbiological verification of NPn diagnosis revealed multiresistant gram-negative bacteria in BAL in groups 1 and 2 and sterile BAL in group 3. CPIS in groups 1 and 2 reflected severe NPn (CPIS > 7); in group 3, it was minimal (<2). Statistically significant differences were detected in the cancer and trauma subgroups between groups 1 and 3 and 2 and 3 on the first and fourth days of study.
ARDS was diagnosed in 2 steps ( Figure 1 ). We used the Murray score to categorize patients into 2 groups: Murray scores ≥2.5 and scores <2.5. Table 2 presents the distribution of patients in these groups and differences between them.
Next, the American-European Consensus Conference on ARDS (AECC) criteria were used, which allowed further differentiation: group 3 (no ARDS); and groups 1 and 2 ( Figure 1 ). All patients in group 1 had positive criteria for ARDS development and presented without left ventricular insufficiency according to clinical and radiological data. Oxygenation Index and Pulmonary Shunt "Cancer" subgroup. According to AECC criteria, ARDS was diagnosed in 6 patients in group 1 and 24 patients in group 2 ( Figure 1 ). All patients in group 1 were diagnosed with the second stage of ARDS with bilateral radiological signs of ARDS. Differences in oxygenation index (OI) were clinically insignificant, dependent on redistribution between the groups; thus, they were not analyzed. Pulmonary shunt (Qs/Qt) in group 1 was significantly greater than normal physiological limits throughout the investigation period and was consistently higher in group 2 during days 1 to 4 of the study (P < .05), and in group 3 during days 1 to 2 of the study (P < .05; Figure 2 ).
"Trauma" subgroup. According to AECC criteria, ARDS was diagnosed in 6 patients in group 1 and 22 patients in group 2 (Figure 1 ). All patients in group 1 were diagnosed with the second stage of ARDS with the eventual development of bilateral radiological signs of ARDS. Differences in OI were clinically insignificant, dependent on the redistribution between the groups; thus, they were not analyzed. Pulmonary shunt (Qs/Qt) in group 1 was significantly greater than normal physiological limits throughout the investigation period and was consistently higher than group 3 on the first day of the study (P < .05; Figure 2 ).
Radiological Data
During the first stage of ARDS diagnosis (Figure 1 ), typical radiological signs of NPn (bilateral lower lobe, polysegmental, right lower lobe, or left lower lobe) and of the second stage of ARDS (bilateral infiltration) were diagnosed in patients of group 1; in patients of group 2, typical radiological signs of NPn. It is noteworthy that we faced significant difficulties in our attempts to diagnose ARDS in NPn using radiological data. During the second step of ARDS diagnosis (Figure 1 ), 13 patients of the "Cancer" subgroup and 9 patients of the "Trauma" subgroup were redistributed from group 2 to group 1 because of the detection of signs of pulmonary edema according to the transpulmonary thermodilution method (see below). These patients (n = 22) had definite radiological signs of NPn (bilateral lower lobe or polysegmental (n = 12, 54.5%), right-sided lower lobe (n = 10, 45.5%), and had none or nonspecific radiological signs of ARDS (NPn without ARDS) at the first step of ARDS diagnosis. Radiological data of group 1 after the second step of ARDS diagnosis are shown in Tables 3 and 4 .
Patients in group 2 presented with typical signs of NPn (bilateral lower lobe or polysegmental ("Cancer" n = 8, 72.7%; "Trauma" n = 7, 53.8%), right-sided lower lobe ("Cancer" n = 2, 18.2%; "Trauma" n = 4, 30.7%), leftsided lower lobe ("Cancer" n = 1, 9.1%; "Trauma" n = 2, 15.5%). There were no radiological signs of left ventricular insufficiency in any group. There were no radiological signs of ARDS or NPn in group 3.
Second Step of ARDS Diagnosis: Extravascular Lung Water Index
"Cancer" subgroup. In 13 patients of group 2 (54.1%), EVLWI was greater than the normal physiological limits (10.2 ± 0.48 mL/kg), which was consistently higher than the remainder of group 2 (7.2 ± 1.2 mL/kg, P A < .05). Signs of pulmonary edema (elevated EVLWI) along with other ARDS criteria (see the appendix) allowed us to diagnose the first stage of ARDS in these patients with NPn and recategorize them to group 1 (ARDS + NPn).
After the second step of ARDS diagnosis, EVLWI in group 1 was greater than the normal physiological limits during the entire study period and was consistently higher than in groups 2 and 3 during days 1 to 3 of the study (P < .05; Figure 3 ). There were no differences among EVLWI and ITBVI, GEDVI, CVP, or volume of intravenous fluid infused among groups during entire study period. "Trauma" subgroup. In 9 patients of group 2 (41%), EVLWI was greater than the normal physiological limits (11.3 ± 0.45 mL/kg), which was consistently higher than group 2 (6.8 ± 1.3 mL/kg, P < .05). Signs of pulmonary edema (elevated EVLWI) along with other ARDS criteria (see the appendix) allowed the diagnosis of the first stage of ARDS in these patients with NPn, and these patients were recategorized to group 1 (ARDS + NPn).
After the second step of ARDS diagnosis, EVLWI in group 1 was greater than the normal physiological limits during the entire study period and was consistently higher than groups 2 and 3 during days 1 to 3 of the study (P < .05; Figure 3 ). There was no correlation detected between EVLWI and ITBVI, GEDVI, CVP, or volume of intravenous fluid infused during the study period.
Pulmonary Vascular Permeability Index
No differences in PVPI were detected between groups and subgroups. PVPI was within normal physiological limits (within 2 standard deviations), including patients in group 1 (Figure 3) . No correlations were detected between PVPI and ITBVI, GEDVI, CVP, or volume of intravenous fluid infused.
Central Hemodynamics
No statistically significant differences in hemodynamic variables were detected between groups and subgroups (Figure 4 ).
Treatments and Outcomes
Diagnosis of early, reversible ARDS stage in patients with NPn provided us with the possibility of providing timely treatment specific for ARDS. The following treatment modalities were used: protective ventilation (100% of patients), recruitment maneuvers (40/40 method, 2 to 3 times a day, 100% of patients), corticosteroids (methylprednisolone 30 mg/kg/d, intravenous [IV] bolus; 70% of patients); N-acetylcysteine (300 mg IV 2 times daily; 63% of patients); restriction of infusion therapy (100% of patients); continuous infusion of albumin + furosemide (albumin 20% 200 to 400 mL IV within 24 hours + furosemide 50 to 100 mg IV within 24 hours, 38% of patients); and extracorporeal membrane oxygenation (1 patient).
To investigate the value of early detection and institution of ARDS therapy, those patients who were enrolled retrospectively (archival data and transpulmonary thermodilution data were available, but no treatment of early ARDS was done) were compared with those patients who were enrolled prospectively (early stage of ARDS, were diagnosed and treated). The duration of controlled ventilation ("Cancer" [n = 9, 21.3 ± 3.8 days], "Trauma" [n = 7, 18.4 ± 5.2 days]) and the duration of the intensive care unit stay ("Cancer" [34.6 ± 7.5 days], "Trauma" [30.5 ± 2.6 days]) were significantly higher in the retrospective subgroup compared with the prospective subgroup ("Cancer" n = 10, 12.5 ± 2.2 days; 15.5 ± 2.6 days, respectively; "Trauma" n = 8, 10.1 ± 2.1 days; 16.2 ± 2.4 days) both in cancer and trauma patients (P < .05).
Discussion
In this study, we investigated the utility of standard (Murray score, AECC) and modern (EVLWI, PVPI) criteria in diagnosing ARDS in NPn in cancer and severely traumatized patients.
The Murray score is widely used in clinical practice, but its utility in diagnosing ARDS in NPn patients has not been investigated. 10 Current data show that the Murray score is powered solely to detect the most severe forms of ARDS in NPn (scores >2.5), which corresponded to the second stage of ARDS. The Murray score did not provide us with the possibility for early diagnosis of ARDS in NPn.
Analysis of the OI and radiological data made it possible to diagnose only the late stage (second) of ARDS in NPn (in 31.6% of patients of the "Cancer" subgroup and 30.8% of patients of the "Trauma" subgroup). It should be kept in mind that OI is a sensitive but a nonspecific index; the entire clinical picture must be considered. OI drops not only in ARDS but also in severe pneumonia, bronchial obstruction, and atelectasis; its level strongly depends on positive end-expiratory pressure. 12 Radiological interpretation in patients with NPn complicated by ARDS is very difficult. There is no possibility of diagnosing the first stage of ARDS using radiological studies, because there are no reliable radiological signs of it. 1, 12, 13 The sensitivity and specificity of radiological data in diagnosing ARDS and NPn is low. AECC on ARDS participants highlighted the need to develop more precise radiological criteria for ARDS. 11 ARDS radiological criteria have 75% sensitivity and 70% specificity; NPn criteria have a high sensitivity (87% to 100%) but a low specificity. Bilateral infiltration is detected with late stages of ARDS or does not appear at all; infiltrates are not always typically distributed on chest radiological examinations since the radiological picture is highly dynamic. 11 Patients with mosaic alterations in ARDS present with no ARDS signs on chest radiological examinations in 59% of cases.
Patients in whom pneumonia is morphologically confirmed, frequently, have no radiological signs of pneumonia. The interpretation of the radiological studies depends on film quality, patient position, pulmonary aeration, concomitant pulmonary pathology, and so on. 15, 16 Rubenfeld et al 17 reported significant interobserver variability in interpretations of chest radiological examinations with bilateral infiltration, especially regarding the nature of the infiltrates. The association of ARDS and pneumonia significantly complicates the existing problem. It is challenging to differentiate pulmonary edema, atelectasis, pulmonary contusion, infarction, and pneumonia in patients on artificial pulmonary ventilation. 18 Computed tomography (CT) is a more reliable method, which allows the detection of pulmonary inhomogeneities, differentiates between ARDS and NPn, diagnoses ARDS stages, and determines the degree of aeration of pulmonary tissues. 6 EVLW accumulation (ie, development of noncardiogenic pulmonary edema) is one of the key elements of ARDS pathogenesis. 12, 13, 15, 16 Experimental and clinical studies have shown that EVLWI increases in ARDS and decreases with effective treatment. Strict control of EVLWI dynamics shortens artificial pulmonary ventilation duration and ICU stay, decreases mortality in noncardiogenic pulmonary edema patients. EVLWI > 10 mL/kg is associated with mortality greater than 60%. According to earlier studies, mortality with EVLWI > 15 mL/kg is greater than 65%, whereas it is 33% in EVLWI < 10 mL/kg. 16, [19] [20] [21] Decrease in EVLWI of less than 7.5 mL/kg leads to a reliable increase of OI. 22 Sakka et al 19 reported 15 patients diagnosed with ARDS with EVLWI within normal physiological limits and 57% of patients without an ARDS diagnosis with elevated EVLWI. Martin et al 20 observed increased EVLWI in more than 50% of patients with severe sepsis without ARDS diagnosis. The results of the abovementioned studies can be assessed either misdiagnosis of ARDS or as failures of EVLWI to confirm an ARDS diagnosis. Dilution methods may underestimate the amounts of EVLW in pulmonary edema due to incomplete thermal indicator distribution in edema fluid, ventilation-perfusion mismatches, and the mathematical assumptions of PiCCOplus algorithm. [18] [19] [20] [21] [22] [23] [24] All patients with the second stage of ARDS presented with significantly elevated EVLWI, which caused oxygenation impairment. Detection of elevated EVLWI, along with other ARDS criteria, in some patients with NPn (Figure 1) provided us with the possibility for early diagnosis of ARDS in NPn, which was impossible to do by means of standard ARDS criteria. The pathogenesis of NPn itself is not associated with pulmonary edema (rise of EVLWI) development. Pulmonary edema is a complication of NPn.
EVLWI can rise with inadequate volume resuscitation, especially with crystalloids. It is associated with prolonged mechanical ventilation periods and worse outcomes. This type of pulmonary edema must be differentiated from the ARDS. [22] [23] [24] Linear regression analysis failed to elucidate any associations between EVLWI and volume of infusions/transfusions in our study, which confirms that increases in EVLWI were not related to excessive volume resuscitation, since all possible cardiogenic reasons for EVLWI elevation were also excluded (CVP, ITBVI, and GEDVI were within the normal range).
Implementation of a reliable method of assessing pulmonary vascular permeability has potential for aiding in ARDS diagnosis. Radionuclide methods with labeled albumin (albumin-1311), Ga 67 , Ga 68 -trasferrin have been used classically. 25 PVPI may be more useful for this purpose. It can be calculated using 3 methods: EVLW/PBV, EVLW/ ITBV, or EVLW/GEDV. 16 Monnet et al 26 confirmed that EVLW/PBV ratio >3 had 85% sensitivity and 100% specificity for ARDS diagnosis. Morisawa and Taira 27 showed that PVPI increases were more significant in patients with pulmonary infections compared with those with extrapulmonary infections. Currently, there are no reliable data regarding which PVPI calculation method is preferable for clinical practice. Shuster 28 reported that PVPI was unchanged even in severe ARDS. Galstyan et al 29 presented PVPI as solely informative in estimating infusion therapy's effects.
The results of the current investigation provides evidence that PVPI calculated by means of transpulmonary thermodilution is not useful in the assessment of pulmonary vascular permeability in patients with ARDS in NPn: No statistically significant PVPI differences were detected between the groups. This can be explained by a simultaneous rise of EVLW and pulmonary blood flow (ITBV, GEDV) in a focus of pulmonary inflammation. 16 Analysis of central hemodynamics indices were not informative in diagnosing ARDS in NPn patients but were widely used to exclude cardiogenic pulmonary edema and to manage the patients. CVP and pulmonary artery occlusion pressure (PAOP) are classically used as indices of preload. CVP is a marker of low specificity. PAOP value decreases in ARDS because of the impact of multiple factors. PAOP increases in 27% of ARDS patients and progressively rises over the disease course and with pulmonary hypertension. 29 Volumetric indexes of preload (GEDV, ITBV) have a great outlook and a high sensitivity. 16, 30 
Conclusions
Modern techniques of pulmonary edema estimationdetection of elevation of EVLWI along with other ARDS diagnostic criteria (oxygenation index, central hemodynamic indices)-may allow earlier diagnosis of ARDS in patients with NPn, allowing for earlier initiation of treatment. Standard diagnostic criteria for ARDS-the Murray score, OI, and radiological criteria-make it possible to diagnose only late stages of ARDS in NPn. This early diagnosis of ARDS in NPn in the current study was associated with decreased duration of artificial ventilation and intensive care unit stay.
